Showing 1761-1770 of 5758 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-37/23755/New Products
https://practicaldermatology.com/columns/new-products/new-products-4/23753/The Current Armamentarium of Topical Therapies to Treat Atopic Dermatitis and Psoriasis
https://practicaldermatology.com/topics/atopic-dermatitis/the-current-armamentarium-of-topical-therapies-to-treat-atopic-dermatitis-and-psoriasis/23748/A review of the alternatives to topical corticosteroids for managing common inflammatory skin diseases.The Best Skincare Products for Eczema, According to Your Peers
https://practicaldermatology.com/topics/atopic-dermatitis/the-best-skincare-products-for-eczema-according-to-your-peers/23747/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-36/23740/DermWire TV: Adbry Approved; Syringoma Option; Confusion over Vaccines and Injectables
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-adbry-approved-syringoma-option-confusion-over-vaccines-and-injectables/20041/Adbry (tralokinumab) from Leo Pharma is the newest biologic approved for moderate to severe atopic dermatitis in adults and is the first IL-13 blocker approved in the US. Pulse Bioscience’s nano-pulse stimulation (NPS) technology shows potential for the treatment of syringoma in a feasibility studyAncillary Services and Alternative Revenue Streams for Dermatologists
https://practicaldermatology.com/topics/practice-management/ancillary-services-and-alternative-revenue-streams-for-dermatologists/23535/Dermatologists have many opportunities to use their skills beyond patient care.DermWireTV: Cosentyx for Kids; Anifrolumab for SLE, Tremfya in PsA at EULAR
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cosentyx-for-kids-anifrolumab-for-sle-tremfya-in-psa-at-eular/19948/FDA has approved Cosentyx (secukinumab) from Novartis for patients as young as six years old. The 2nd Annual San Diego Dermatology Symposium kicks off as a live Virtual Experience next Friday. A post-hoc analysis of pooled data from the TULIP Phase 3 clinical trials shows that anifrolumab improvesConjunctival Squamous Cell Carcinoma: A Video-Illustration of a Surgical Approach
https://practicaldermatology.com/youngmd-connect/resident-resource-center/conjunctival-squamous-cell-carcinoma-a-video-illustration-of-a-surgical-approach/23378/Physician Spotlight: Adam J. Friedman, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-adam-j-friedman-md/23375/